On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing the state’s law which banned over-the-counter (OTC) sales of pseudoephedrine (PSE). Since 2010, Mississippi has categorized PSE as a schedule III controlled substance available to consumers only with a doctor’s prescription. In addition to returning PSE to OTC status, the bill directs the state to utilize the National Precursor Log Exchange (NPLEx) to govern sales of medications containing the ingredient. Starting on January 1, 2022, Mississippi will become the 36th state to utilize NPLEx to govern all PSE sales.
Oregon is now the only state in the country to require a doctor’s prescription for the purchase of PSE. The legislature there is considering repealing their own law, which has been in place since 2006. The Oregon bill, H.B. 2648, could be heard as soon as next week in the House Health Care Committee. CHPA strongly opposes prescription-only policies for PSE and worked closely with Mississippi lawmakers in producing this historic result.
Read CHPA's full press release and check out this video of Carlos Gutierrez, CHPA's vice president of state and local government affairs, discussing this important public health victory in Mississippi.